NEW YORK and CAESAREA, Israel, March 18, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its fourth quarter and year-end 2018 results on Monday, March 25, and host a conference call the same morning at 9:00 am EDT.  

DarioHealth Corp.

The Company will discuss its fourth quarter and year-end 2018 operating and financial results and its strategy and outlook for 2019.

The call will be hosted by Erez Raphael, Chief Executive Officer, Olivier Jarry, President and Chief Commercial Officer, and Zvi Ben-David, Chief Financial Officer.

The live call can be accessed by dialing 1-844-602-0380 or 1-862-298-0970 (international). Participants should ask for the DarioHealth Earnings Conference Call. The conference call will also be available via live webcast at: http://www.investornetwork.com/event/presentation/45131

Conference Call Details:
Date: Monday, March 25, 2019 
Time: 9:00am EDT  
Dial-in Number: 1-844-602-0380  
International Dial-in Number: 1-862-298-0970  
Webcast: https://www.investornetwork.com/event/presentation/45131

Participants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through April 8, 2019. To listen to the replay, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 45131. The webcast replay will be available through June 25, 2019.

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading global Digital Therapeutics (DTx) company revolutionizing the way people manage their health across the chronic condition spectrum. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we developed a novel approach that empowers individuals to adjust their lifestyle in a personalized way. Our Cross Functional Team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Already one of the highest rated diabetes solutions, its user-centric approach is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets.

DarioHealth Corporate Contact: Joao Mendes-Roter, VP Marketing, joao@mydario.com, 1-914-775-5548

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/dariohealth-to-host-fourth-quarter-and-year-end-2018-conference-call-march-25-2019-300813872.html

SOURCE DarioHealth Corp.

Copyright 2019 PR Newswire

DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more DarioHealth Charts.
DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more DarioHealth Charts.